Skip to Content
  • Rank
  • Prev Rank
  • Industry
  • Industry Rank
  • Prev Industry Rank
  • HQ Country
  • Website

Despite having to pay $1 billion in fees and taxes related to the healthcare overhaul in 2013 — an amount it expects to pay this year too — Johnson & Johnson’s fourth quarter profit grew to $3.5 billion from $2.57 billion, led by pharmaceutical sales that were up 10.9% for the year. In January — in an unprecedented step that was applauded by the medical science community — J&J said it would release its clinical trial data for drugs and medical equipment like artificial hips and knees.

Created with sketchtool.Created with sketchtool.Looking for leads, investment insights, or competitive intelligence?Buy Now

Nine Key Attributes of Reputation

People management1
Use of corporate assets2
Social responsibility1
Quality of management1
Financial soundness1
Long-term investment value1
Quality of products / services8
Global competitiveness2